|
06-05-2010, 05:17 PM
|
|||
|
|||
Amgen Drug Delays Cancer Patients Fractures Longer Than Zometa
June 5 (Bloomberg) -- Amgen Inc .s bone-strengthening drug denosumab delayed fractures and complications longer than Novartis AG s Zometa in men whose prostate cancer had spread to their bones, a study said.
    
|
 |
| Thread Tools | |
| Display Modes | |
|
|
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Cancer Patients Live Longer With Palliative Care | cancerfr | Latest Cancer News | 0 | 08-21-2010 02:37 AM |
| Amgen Drug Gets Priority Review For Bone Cancer | cancerfr | Bone Cancer | 0 | 07-17-2010 09:40 AM |
| Newly Diagnosed Multiple Myeloma Patients - Zometa Added To Chemotherapy Shown To Con | cancerfr | Adrenocortical Carcinoma | 0 | 06-14-2010 03:56 PM |
| Drug That Restricts Blood Supply To Prostate Tumors Delays Disease Progression | cancerfr | Extracranial Germ Cell Tumor | 0 | 06-11-2010 06:28 PM |
| Test predicts effects of Amgen cancer drug | cancerfr | Extracranial Germ Cell Tumor | 0 | 04-19-2010 02:21 AM |
Linear Mode
